Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Johnson David Michael Create: Alert

All | News | Filings
Date FiledTypeDescription
10/05/2023 4 Johnson David Michael (Director) has filed a Form 4 on Aura Biosciences, Inc.
Txns: Bought 13,500 shares @ $8.2713, valued at $111.7k
Bought 6,566 shares @ $8.6068, valued at $56.5k
06/16/2023 4 Johnson David Michael (Director) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.
Txns: Granted 19,059 shares @ $0
06/09/2023 4 Johnson David Michael (Director) has filed a Form 4 on Aura Biosciences, Inc.
Txns: Granted 16,000 options to buy @ $12.83, valued at $205.3k
01/09/2023 4 Johnson David Michael (Director) has filed a Form 4 on Aura Biosciences, Inc.
Txns: Bought 300 shares @ $10, valued at $3k
Bought 96 shares @ $10, valued at $960
Bought 700 shares @ $10.5, valued at $7.4k
Bought 904 shares @ $10.51, valued at $9.5k
12/30/2022 4 Johnson David Michael (Director) has filed a Form 4 on Aura Biosciences, Inc.
Txns: Bought 2,000 shares @ $9.75, valued at $19.5k
Bought 2,000 shares @ $9.75, valued at $19.5k
12/15/2022 4 Johnson David Michael (Director) has filed a Form 4 on Aura Biosciences, Inc.
Txns: Bought 5,000 shares @ $12.37, valued at $61.9k
Bought 5,000 shares @ $12.37, valued at $61.9k
06/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/17/2021 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
11/02/2021 4 Johnson David Michael (Director) has filed a Form 4 on Aura Biosciences, Inc.
Txns: Converted 139,672 shares @ $0
Converted 139,672 convertible preferred @ $0
10/29/2021 4 Johnson David Michael (Director) has filed a Form 4 on Aura Biosciences, Inc.
Txns: Granted 24,000 options to buy @ $14, valued at $336k
10/28/2021 3 Johnson David Michael (Director) has filed a Form 3 on Aura Biosciences, Inc.
10/04/2021 4 Johnson David Michael (Director) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.
Txns: Sold 4,892 shares @ $65.9501, valued at $322.6k
Sold 7,904 shares @ $66.579, valued at $526.2k
Sold 100 shares @ $67.2, valued at $6.7k
06/08/2021 4 Johnson David Michael (Director) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.
Txns: Granted 5,000 shares @ $0
Granted 15,000 options to buy @ $52.25, valued at $783.8k
04/05/2021 4 Johnson David Michael (Director) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.
Txns: Sold 12,897 shares @ $43.5001, valued at $561k
12/03/2020 4 Johnson David Michael (Director) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.
Txns: Bought 4,000 shares @ $18, valued at $72k
Sold 1,600 shares @ $49.8, valued at $79.7k
Sold 3,868 shares @ $50.82, valued at $196.6k
Sold 4,603 shares @ $51.61, valued at $237.6k
Sold 2,825 shares @ $52.72, valued at $148.9k
04/09/2020 4 Johnson David Michael (Director) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.
Txns: Granted 51,587 shares @ $0
04/03/2020 3 Johnson David Michael (Director) has filed a Form 3 on Zentalis Pharmaceuticals, LLC

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy